Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3678-3681

  Ursin, Giske ^a   Henderson, Brian E ^a   Haile, Robert W ^a   Pike, Malcolm C ^a   Zhou, Nianmin ^a   Diep, Anh ^a   Bernstein, Leslie ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; ENVIRONMENTAL FACTOR; ETHNIC GROUP; FEMALE; GENE MUTATION; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; PENETRANCE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL; EXERCISE; FEMALE; GENES, BRCA1; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HUMANS; JEWS; MUTATION; RISK FACTORS;

EID: 0030865837     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Fitzgerald, M. G., MacDonald, D. J., Krainer, M., Hoover, I., O'Neil, E., Unsal, H., Silva-Arrieto, S., Finkelstein, D. M., Beer-Romero, P., Englert, C., Sgroi, D. C., Smith, B. L., Younger, J. W., Garber, J. E., Duda, R. B., Mayzel, K. A., Isselbacher, K. J., Friend, S. H., and Haber, D. A. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N. Engl. J. Med., 334: 143-149, 1996.
2. Offit, K., Gilewski, T., McGuire, P., Schluger, A., Hampel, H., Brown, K., Swensen, J., Neuhausen, S., Skolnick, M., Norton, L., and Goldgar, D. Germ-line BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet, 347: 1643-1645, 1996.
3. Neuhausen, S., Gilewski, T., Norton, L., Tran, T., McGuire, P., Swensen, J., Hampel, H., Borgen, P., Brown, K., Skolnick, M., Shattuck-Eidens, D., Jhanwar, S., Goldgar, D., and Offit, K. Recurrent BRCA2 6174delT mutations in Ashkenzai Jewish women affected by breast cancer. Nat. Genet., 13: 126-128, 1996.
4. Krainer, M., Silva-Arrieta, S., Fitzgerald, M. G., Shimada, A., Ishioka, C., Kanamaru, R., MacDonald, D. J., Unsal, H., Finkelstein, D. M., Bowcock, A., Isselbacher, K. J., and Haber, D. A. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N. Engl. J. Med., 336: 1416-1421, 1997.
5. Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., and Tucker, M. A. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. Med., 336: 1401-1408, 1997.
6. Narod, S. A., Goldgar, D., Cannon-Albright, L., Weber, B., Moslehi, R., Ives, E., Lenoir, G., and Lynch, H. Risk modifiers in carriers of BRCA1 mutations. Int. J. Cancer, 64: 394-398, 1995.
7. Gudas, J. M., Nguyen, H., Li, T., and Cowan, K. H. Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res., 55: 4561-4565, 1995.
8. Bernstein, L. E., Henderson, B. E., Hanisch, R., Sullivan-Halley, J., and Ross, R. K. Physical exercise and reduced risk of breast cancer in young women. J. Natl. Cancer Inst., 86: 1403-1408, 1994.
9. Shattuck-Eidens, D., McClure, M., Simard, J., LaBrie, F., Narod, S., Couch, F., Hoskins, K., Weber, B., Castillas, L., Erdos, M., Brody, L., Friedman, L., Ostermeyer, E., Szabo, C., King, M-C., Jhanwar, S., Offit, K., Norton, L., Gilewski, T., Lubin, M., Osborne, M., Black, D., Boyd, M., Steel, M., Ingles, S., Haile, R., Lindblom, A., Olsson, H., Borg, A., Bishop, D. T., Solomon, E., Radice, P., Spatti, G., Gayther, S., Ponder, B., Warren, W., Stratton, M., Liu, Q., Fujimura, F., Lewis, C., Skolnick, M., and Goldgar, D. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening. J. Am. Med. Assoc., 273: 535-541, 1995.
10. Piegorsch, W. W., Weinberg, C. R., and Taylor, J. A. Non-hierarchical logistic models and case-only design for assessing susceptibility in population-based case-control studies. Stat. Med., 13: 153-162, 1994,
11. Begg, C. B., and Zhang, Z. F. Statistical analysis of molecular epidemiology studies employing case-case series. Cancer Epidemiol. Biomark. Prev., 3: 173-175, 1994.
12. Ravnihar, B., Zakelj, M. P., Kosmelj, K., and Stare, J. A case-control study of breast cancer in relation to oral contraceptive use in Slovenia. Neoplasma (Bratisl.), 35: 109-121, 1988.
13. Miller, D. R., Rosenberg, L., Kaufman, D. W., Stolley, P., Warshauer, M. E., and Shapiro, S. Breast cancer before age 45 and oral contraceptive use: new findings. Am. J. Epidemiol., 129: 269-280, 1989.
14. Brinton, L. A., Daling, J. R., Liff, J. M., Schoenberg, J. B., Malone, K. E., Stanford, J. L., Coates, R. J., Gammon, M. D., Hanson, L., and Hoover, R. N. Oral contraceptives and breast cancer risk among younger women. J. Natl. Cancer Inst., 87: 827-835, 1995.
15. Rosenberg, L., Palmer, J. R., Rao, S., Zauber, A. G., Strom, B. L., Warshauer, M. E., Harlap, S., and Shapiro, S. Case-control study of oral contraceptive use and risk of breast cancer. Am. J. Epidemiol., 143: 25-37, 1996.
16. United Kingdom National Case-Control Study Group. Oral contraceptive use and breast cancer risk in young women: subgroup analyses. Lancet, 335: 1507-1509, 1990.
17. White, E., Malone, K. E., Weiss, N. S., and Daling, J. R. Breast cancer among young U.S. women in relation to oral contraceptive use. J. Natl. Cancer Inst., 86: 505-514, 1994.
18. Olsson, H., Jernström, H., Alm, P., Kreipe, H., Ingvar, C., Jönsson, P-E., and Ryden, S. Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors. Breast Cancer Res. Treat., 40: 187-196, 1996.
19. Marquis, S. T., Rajan, J. V., Wynshaw-Boris, A., Xu, J., Yin, G. Y., Abel, K. J., Weber, B. L., and Chodosh, L. A. The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nat. Genet., 11: 17-26, 1995.
20. Lane, F. T., Deng, C., Elson, A., Lyu, M. S., Kozak, C. A., and Leder, P. Expression of BRCA1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev., 9: 2712-2722, 1995.